Astera Labs (NASDAQ:ALAB) Trading Down 5.3% – Should You Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 5.3% during trading on Thursday . The company traded as low as $280.53 and last traded at $284.53. Approximately 3,187,307 shares were traded during trading, a decline of 40% from the average daily volume of 5,292,045 shares. The stock had previously closed at $300.54.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ALAB shares. Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. TD Cowen lowered their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Bank of America increased their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Citigroup restated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Finally, Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Trading Down 5.3%

The firm has a market capitalization of $49.36 billion, a PE ratio of 140.86 and a beta of 3.77. The company has a fifty day moving average price of $321.34 and a two-hundred day moving average price of $258.86.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other news, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the transaction, the director directly owned 3,970 shares of the company’s stock, valued at $1,237,965.10. The trade was a 69.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 592,244 shares of company stock valued at $209,729,973. 10.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. California State Teachers Retirement System grew its stake in shares of Astera Labs by 49,273.2% in the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock valued at $48,378,580,000 after purchasing an additional 99,955,684 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Astera Labs during the second quarter worth approximately $6,609,581,000. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the second quarter worth approximately $1,061,791,000. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Finally, Amundi lifted its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.